Neurophysiological effects of hallucinogens on serotonergic neuronal systems
- PMID: 7177511
- DOI: 10.1016/0149-7634(82)90033-1
Neurophysiological effects of hallucinogens on serotonergic neuronal systems
Abstract
Low intravenous doses of the hallucinogen d-lysergic acid diethylamide (LSD) markedly suppress the discharge of serotonin (5-HT)-containing neurons in the dorsal raphe nucleus of the rat. Microiontophoretically applied LSD also inhibits the firing of 5-HT neurons, indicating that the inhibitory effect is mediated directing on 5-HT neurons. Forebrain neurons receiving a major serotonergic input are relatively insensitive to LSD. Other indole hallucinogens (i.e., psilocin, dimethyltryptamine, and 5-methoxydimethyltryptamine) also preferentially inhibit raphe firing as compared to postsynaptic forebrain neurons. These observations led to the hypothesis that hallucinogens produce their psychoactive effects by acting preferentially upon 5-HT autoreceptors in the dorsal raphe allowing postsynaptic neurons to escape from the tonic inhibitory action of 5-HT neurons. However, problems exist with the concept that hallucinogens produce their psychoactive effects by disinhibiting postsynaptic neurons. First, the time course of the behavioral and neuronal effects of LSD do not correlate. Second, 5-HT neurons do not become tolerant to the inhibitory actions of LSD. Third, the hallucinogen mescaline fails to directly inhibit 5-HT neurons. Finally, the nonhallucinogen lisuride markedly suppresses the discharges of 5-HT neurons. These observations suggest that postsynaptic actions of hallucinogens may be of prime importance in producing their psychedelic effects. Evidence is presented to suggest that the hallucinogens may act postsynaptically to sensitize both serotonergic and noradrenergic receptors. It is suggested that a mechanism of receptor sensitization, in distinction to disinhibition, might account for the altered perceptual reactivity produced by these drugs.
Similar articles
-
Effects of hallucinogenic drugs on serotonergic neuronal systems.Pharmacol Biochem Behav. 1986 Feb;24(2):359-63. doi: 10.1016/0091-3057(86)90366-7. Pharmacol Biochem Behav. 1986. PMID: 2869504
-
Comparative effects of LSD and lisuride: clues to specific hallucinogenic drug actions.Pharmacol Biochem Behav. 1986 Feb;24(2):365-79. doi: 10.1016/0091-3057(86)90367-9. Pharmacol Biochem Behav. 1986. PMID: 3952127
-
Differential effects of hallucinogenic drugs on the activity of serotonin-containing neurons in the nucleus centralis superior and nucleus raphe pallidus in freely moving cats.J Pharmacol Exp Ther. 1984 Jan;228(1):94-102. J Pharmacol Exp Ther. 1984. PMID: 6694110
-
Nerve terminal effects of indoleamine psychotomimetics on 5-hydroxytryptamine.Neurosci Biobehav Rev. 1982 Winter;6(4):483-7. doi: 10.1016/0149-7634(82)90029-x. Neurosci Biobehav Rev. 1982. PMID: 6294571 Review.
-
Serotonin and hallucinogens.Neuropsychopharmacology. 1999 Aug;21(2 Suppl):16S-23S. doi: 10.1016/S0893-133X(98)00135-3. Neuropsychopharmacology. 1999. PMID: 10432484 Review.
Cited by
-
The Selective 5HT2A Receptor Agonist, 25CN-NBOH Exerts Excitatory and Inhibitory Cellular Actions on Mouse Medial Prefrontal Cortical Neurons.Synapse. 2025 Mar;79(2):e70014. doi: 10.1002/syn.70014. Synapse. 2025. PMID: 40128102 Free PMC article.
-
Mechanisms and molecular targets surrounding the potential therapeutic effects of psychedelics.Mol Psychiatry. 2023 Sep;28(9):3595-3612. doi: 10.1038/s41380-023-02274-x. Epub 2023 Sep 27. Mol Psychiatry. 2023. PMID: 37759040 Free PMC article. Review.